These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 17690696)

  • 1. Expression of MUM1/IRF4 mRNA as a prognostic marker in patients with multiple myeloma.
    Heintel D; Zojer N; Schreder M; Strasser-Weippl K; Kainz B; Vesely M; Gisslinger H; Drach J; Gaiger A; Jäger U; Ludwig H
    Leukemia; 2008 Feb; 22(2):441-5. PubMed ID: 17690696
    [No Abstract]   [Full Text] [Related]  

  • 2. Quantitation of multiple myeloma oncogene 1/interferon-regulatory factor 4 gene expression in malignant B-cell proliferations and normal leukocytes.
    Yamada M; Asanuma K; Kobayashi D; Moriai R; Yajima T; Yagihashi A; Yamamori S; Watanabe N
    Anticancer Res; 2001; 21(1B):633-8. PubMed ID: 11299818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical detection of multiple myeloma 1/interferon regulatory factor 4 (MUM1/IRF-4) in canine plasmacytoma: comparison with CD79a and CD20.
    Ramos-Vara JA; Miller MA; Valli VE
    Vet Pathol; 2007 Nov; 44(6):875-84. PubMed ID: 18039900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lenalidomide downregulates the cell survival factor, interferon regulatory factor-4, providing a potential mechanistic link for predicting response.
    Lopez-Girona A; Heintel D; Zhang LH; Mendy D; Gaidarova S; Brady H; Bartlett JB; Schafer PH; Schreder M; Bolomsky A; Hilgarth B; Zojer N; Gisslinger H; Ludwig H; Daniel T; Jäger U; Chopra R
    Br J Haematol; 2011 Aug; 154(3):325-36. PubMed ID: 21707574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MUM1/IRF4: A Review.
    Gualco G; Weiss LM; Bacchi CE
    Appl Immunohistochem Mol Morphol; 2010 Jul; 18(4):301-10. PubMed ID: 20182347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple myeloma oncogene 1 (MUM1)/interferon regulatory factor 4 (IRF4) upregulates monokine induced by interferon-gamma (MIG) gene expression in B-cell malignancy.
    Uranishi M; Iida S; Sanda T; Ishida T; Tajima E; Ito M; Komatsu H; Inagaki H; Ueda R
    Leukemia; 2005 Aug; 19(8):1471-8. PubMed ID: 15959530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deregulation of MUM1/IRF4 by chromosomal translocation in multiple myeloma.
    Iida S; Rao PH; Butler M; Corradini P; Boccadoro M; Klein B; Chaganti RS; Dalla-Favera R
    Nat Genet; 1997 Oct; 17(2):226-30. PubMed ID: 9326949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A polymorphism in the 3' UTR of IRF4 linked to susceptibility and pathogenesis in chronic lymphocytic leukaemia and Hodgkin lymphoma has limited impact in multiple myeloma.
    Pratt G; Fenton JA; Allsup D; Fegan C; Morgan GJ; Jackson G; Sunter NJ; Hall AG; Irving JA; Allan JM
    Br J Haematol; 2010 Aug; 150(3):371-3. PubMed ID: 20408839
    [No Abstract]   [Full Text] [Related]  

  • 9. Comprehensive genomic profiling of IgM multiple myeloma identifies IRF4 as a prognostic marker.
    Ryu D; Kim HJ; Joung JG; Lee HO; Bae JS; Kim SJ; Kim H; Park WY; Kim K
    Oncotarget; 2016 Jul; 7(30):47127-47133. PubMed ID: 27223072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variant IRF4/MUM1 associates with CD38 status and treatment-free survival in chronic lymphocytic leukaemia.
    Allan JM; Sunter NJ; Bailey JR; Pettitt AR; Harris RJ; Pepper C; Fegan C; Hall AG; Deignan L; Bacon CM; Pointon JC; Houlston RS; Broderick P; Mainou-Fowler T; Jackson GH; Summerfield G; Evans PA; Strefford JC; Parker A; Oscier D; Pratt G; Allsup DJ
    Leukemia; 2010 Apr; 24(4):877-81. PubMed ID: 20090783
    [No Abstract]   [Full Text] [Related]  

  • 11. Upregulated MCL1 mRNA expression in multiple myeloma lacks association with survival.
    Mylin AK; Rasmussen T; Lodahl M; Dahl IM; Knudsen LM
    Br J Haematol; 2009 Mar; 144(6):961-3. PubMed ID: 19077158
    [No Abstract]   [Full Text] [Related]  

  • 12. Elevated interferon regulatory factor 4 levels in patients with allergic asthma.
    Chen X; Gao YD; Yang J
    J Asthma; 2012 Jun; 49(5):441-9. PubMed ID: 22515488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MUM1 expression in cutaneous CD30+ lymphoproliferative disorders: a valuable tool for the distinction between lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma.
    Kempf W; Kutzner H; Cozzio A; Sander CA; Pfaltz MC; Müller B; Pfaltz M
    Br J Dermatol; 2008 Jun; 158(6):1280-7. PubMed ID: 18410414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative polymerase chain reaction analysis of mdr1 mRNA in multiple myeloma cell lines and clinical specimens.
    Futscher BW; Blake LL; Gerlach JH; Grogan TM; Dalton WS
    Anal Biochem; 1993 Sep; 213(2):414-21. PubMed ID: 8238918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The transcription factor IRF4 represses proapoptotic BMF and BIM to licence multiple myeloma survival.
    Fedele PL; Liao Y; Gong JN; Yao Y; van Delft MF; Low MSY; Tai L; Herold MJ; Jackson JT; Teh CE; Tan T; O'Reilly LA; Tellier J; Grigoriadis G; Huang DCS; Shi W; Nutt SL; Willis SN
    Leukemia; 2021 Jul; 35(7):2114-2118. PubMed ID: 33149265
    [No Abstract]   [Full Text] [Related]  

  • 16. Concurrent p16 methylation pattern as an adverse prognostic factor in multiple myeloma: a methylation-specific polymerase chain reaction study using two different primer sets.
    Park G; Kang SH; Lee JH; Suh C; Kim M; Park SM; Kim TY; Oh B; Min HJ; Yoon SS; Yang IC; Cho HI; Lee DS;
    Ann Hematol; 2011 Jan; 90(1):73-9. PubMed ID: 20721556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IRF4 promotes cell proliferation by JNK pathway in multiple myeloma.
    Zhang S; Xu J; Wu S; Wang R; Qu X; Yu W; Li J; Chen L
    Med Oncol; 2013; 30(2):594. PubMed ID: 23666852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prognostic factors in multiple myeloma. Critical analysis based on a multicenter study of 53 cases].
    Zakraoui L; Cheour I; Jeridi T; Jellouli N; Bergaoui N; Moalla M; Abdeladhim A; Karoui M; Ben Hamida A; Zouari R
    Tunis Med; 1988 Oct; 66(10):663-72. PubMed ID: 3065992
    [No Abstract]   [Full Text] [Related]  

  • 19. IRF4 regulates IL-10 gene expression in CD4(+) T cells through differential nuclear translocation.
    Lee CG; Hwang W; Maeng KE; Kwon HK; So JS; Sahoo A; Lee SH; Park ZY; Im SH
    Cell Immunol; 2011; 268(2):97-104. PubMed ID: 21440248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum BAFF levels are related to angiogenesis and prognosis in patients with multiple myeloma.
    Fragioudaki M; Tsirakis G; Pappa CA; Aristeidou I; Tsioutis C; Alegakis A; Kyriakou DS; Stathopoulos EN; Alexandrakis MG
    Leuk Res; 2012 Aug; 36(8):1004-8. PubMed ID: 22498341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.